[Policy Recommendation] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2023 (May 24, 2023)
date : 6/7/2023
Tags: AMR
On May 24, 2023, AMR Alliance Japan (Secretariat: Health and Global Policy Institute) released “Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2023” to promote infectious disease control measures to combat antimicrobial resistance (AMR). The content of the recommendations was as follows.
Promote countermeasures for antimicrobial resistance (AMR) with a One Health approach from perspectives including economic security and serve as a global leader in strengthening preparedness against the threat of infectious disease.
Every year since 2016, Japan’s Basic Policies on Economic and Fiscal Management and Reform have mentioned strengthening efforts to promote AMR control and expanding systems for research, testing, and treatment. Mention of this objective was expanded in 2022 to state, “Japan will also comprehensively examine concrete methods to secure therapeutic drugs for drug-resistant bacteria such as market incentives in measures designed to counter drug resistance, draw conclusions based on these examinations, and then play a leading role in international discussions.” In this manner, Japan has emphasized the importance of AMR control.
As described in the attachment titled, “Promoting Antimicrobial Resistance (AMR) Countermeasures in the Basic Policy on Economic and Fiscal Management and Reform 2023 Recommendation Background,” progress is being made in measures to combat AMR both in Japan and around the world. Looking ahead to the 79th session of the UN General Assembly (UNGA 79) in 2024 and beyond, it will be crucial for Japan to fulfill its commitments to the international community in its capacity as G7 President in 2023 based on the idea that infectious disease control cannot be fully implemented by countries acting alone.
“Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2023” and “Promoting Antimicrobial Resistance (AMR) Countermeasures in the Basic Policy on Economic and Fiscal Management and Reform 2023 Recommendation Background” can be found here.
Top Research & Recommendations Posts
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Event Report and Discussion Points] AI Diagnostic Support Project Expert Meeting: “The Roles of Industry, Government, Academia, and Civil Society in the Era of AI-Assisted Diagnosis” (May 25, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Dementia Project “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (April 27, 2026)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-05-15
[Registration Open] (Webinar) The 2nd J-PEP Seminar – A New Framework for Providing Information on Clinical Trial Participant Recruitment – Legal Points to Consider from the Perspective of Meaningful Involvement (June 15, 2026)
-
2026-05-18
[Registration Closed] Kick-off Panel Discussion “From Africa and Japan, Drawing from Perspectives Around the World:A Platform for Cultivating a Philosophical Health Dialogue Together” (June 15, 2026)
-
2026-05-19
[Registration Open] (Webinar) HGPI Special Seminar “Building a Society Where People Live with Blood Disorders: The Future of Blood Disorder Policy as Examined from the Frontlines of Home-Based Care × Lived Experience Research” (June 12, 2026)
-
2026-06-04
[Registration Open] (Webinar) The 3rd J-PEP Seminar “Social Participation of People with Intractable Diseases and the Potential of a New Way of Working — ‘RD Workers’ — Lessons from Policy Advocacy Practice” (July 22, 2026)



